Serological methods should meet the needs of leishmaniasis diagnosis due to their high
sensitivity and specificity, economical and adaptable rapid diagnostic test format, and ease …

Amid the escalating challenges of antibiotic resistance, bacterial infections have emerged as
a global threat. Bacteriophages (phages), viral entities capable of selectively infecting …

Visceral leishmaniasis (VL) represents a serious public health problem, as Leishmania
infantum is one of main disease causative agents in the Americas. In a previous …

Visceral leishmaniasis (VL) is a potentially fatal disease, in which the treatment based on
chemotherapy is considered toxic. The cure of disease is associated with the life-long Th1 …

Background Accurate and accessible diagnosis is key for the control of visceral
leishmaniasis (VL). Yet, current diagnostic tests for VL have severe limitations: they are …

Leishmania braziliensis is responsible for most cases of human tegumentary leishmaniasis
(HTL) and has caused a wide range of clinical manifestations, including cutaneous (CL) and …

New candidates for serological markers against leishmaniasis are required to be identified,
since the presence of high titers of anti-Leishmania antibodies remain detected in sera of …

Serological tests are preferentially used for the diagnosis of Chagas' disease (CD) during
the chronic phase because of the low parasitemia and high anti-Trypanosoma cruzi …

Visceral leishmaniasis (VL) still represents a serious public health problem in Brazil due to
the inefficiency of the control measures currently employed, that included early diagnosis …

Abstract In the Americas, Brazil is responsible by 90% of the cases registered of visceral
leishmaniasis (VL), and Leishmania infantum is the most common parasite species …